Anna Wolszczak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anna Wolszczak has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Dastin Misiaszek
University Clinical Center of the Medical University of Warsaw
9 shared publications - Weronika Martynowska
Independent Public Clinical Hospital of Prof. W. Orlowski CMKP in Warsaw, Czerniakowska 231, 00-416 Warsaw, Poland
9 shared publications - Natalia Grabowska
Specjalistyczny Szpital Wojewódzki w Ciechanowie: Ciechanów, Mazowieckie, Poland
8 shared publications - Alicja Graczyk
Bielański Hospital named after Father Jerzy Popiełuszko, Warsaw, Poland
7 shared publications - Jakub Motor
Medical University of Lodz, Łódź, Poland
7 shared publications - Michał Hajt
University Clinical Center of the Medical University of Warsaw, Poland
7 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
MYOCARDIAL INFARCTION IN ATHLETES: EPIDEMIOLOGY, PATHOPHYSIOLOGICAL MECHANISMS, DIAGNOSTIC CHALLENGES, AND PREVENTIVE STRATEGIES
Myocardial infarction (MI) among athletes is an uncommon but clinically significant event that has attracted growing attention because of its potential to cause sudden cardiac death (SCD) and long-term morbidity in an otherwise healthy population. This review synthesizes current literature on the epidemiology, pathophysiology, diagnostic evaluation, and preventive strategies for MI in athletes across age groups. In athletes younger than approximately 35 years, MI is rare and is more often attributable to non-atherosclerotic mechanisms—congenital coronary artery anomalies, spontaneous coronary artery dissection, coronary artery spasm, myocardial bridging, an oxygen supply–demand mismatch related to hypertrophic cardiomyopathy, or performance-enhancing substance use—than to classic atherosclerotic coronary artery disease. In masters athletes, generally older than 35 years, atherosclerotic plaque rupture or erosion, frequently triggered by the acute hemodynamic stress of intense exertion, becomes the predominant mechanism. Preparticipation cardiovascular screening, incorporating structured history-taking, physical examination, and standardized electrocardiographic interpretation criteria, together with the widespread availability of automated external defibrillators and bystander cardiopulmonary resuscitation training, constitutes the principal preventive strategy, although its optimal design and cost-effectiveness remain debated. Following an acute event, individualized, shared-decision-making approaches to return-to-play balance the cardiovascular and psychological benefits of continued exercise against residual arrhythmic and ischemic risk. Continued research into advanced imaging biomarkers, genetic testing, and risk-stratification tools is needed to refine clinical care for this distinctive population.
- 23 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Open AccessMYOCARDIAL INFARCTION IN ATHLETES: EPIDEMIOLOGY, PATHOPHYSIOLOGICAL MECHANISMS, DIAGNOSTIC CHALLENGES, AND PREVENTIVE STRATEGIES
Myocardial infarction (MI) among athletes is an uncommon but clinically significant event that has attracted growing attention because of its potential to cause sudden cardiac death (SCD) and long-term morbidity in an otherwise healthy population. This review synthesizes current literature on the epidemiology, pathophysiology, diagnostic evaluation, and preventive strategies for MI in athletes across age groups. In athletes younger than approximately 35 years, MI is rare and is more often attributable to non-atherosclerotic mechanisms—congenital coronary artery anomalies, spontaneous coronary artery dissection, coronary artery spasm, myocardial bridging, an oxygen supply–demand mismatch related to hypertrophic cardiomyopathy, or performance-enhancing substance use—than to classic atherosclerotic coronary artery disease. In masters athletes, generally older than 35 years, atherosclerotic plaque rupture or erosion, frequently triggered by the acute hemodynamic stress of intense exertion, becomes the predominant mechanism. Preparticipation cardiovascular screening, incorporating structured history-taking, physical examination, and standardized electrocardiographic interpretation criteria, together with the widespread availability of automated external defibrillators and bystander cardiopulmonary resuscitation training, constitutes the principal preventive strategy, although its optimal design and cost-effectiveness remain debated. Following an acute event, individualized, shared-decision-making approaches to return-to-play balance the cardiovascular and psychological benefits of continued exercise against residual arrhythmic and ischemic risk. Continued research into advanced imaging biomarkers, genetic testing, and risk-stratification tools is needed to refine clinical care for this distinctive population.
- Open Access
- 22 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 74, 75144
The role of physical activity in secondary prevention after myocardial infarction
Physical activity (PA) is one of the fundamental elements of secondary prevention after acute coronary syndrome (ACS) and myocardial infarction (MI), as well as a key component of cardiac rehabilitation (CR). Available evidence indicates that higher levels of PA are associated with lower mortality, reduced risk of recurrent cardiovascular events, better physical capacity, improved quality of life, and more favorable control of cardiovascular risk factors. Despite these documented benefits, participation in CR and long-term maintenance of the recommended level of PA remain insufficient. Aim of the studyThe aim of this study was to present the role of PA in secondary prevention after MI, with particular emphasis on its impact on prognosis, physical capacity, quality of life, cardiovascular risk factors, and the importance of CR. Material and methodsA narrative literature review was conducted, including observational studies, randomized clinical trials, meta-analyses, and review articles concerning PA, CR, and secondary prevention after ACS and MI. ConclusionsPA and exercise-based CR are fundamental elements of post-MI care. Their benefits include improved prognosis, physical performance, quality of life, and modification of major cardiovascular risk factors. Improving access to CR, patient education, and long-term maintenance of PA should remain one of the main goals of secondary prevention.
- 22 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 74, 75144
Open AccessThe role of physical activity in secondary prevention after myocardial infarction
Physical activity (PA) is one of the fundamental elements of secondary prevention after acute coronary syndrome (ACS) and myocardial infarction (MI), as well as a key component of cardiac rehabilitation (CR). Available evidence indicates that higher levels of PA are associated with lower mortality, reduced risk of recurrent cardiovascular events, better physical capacity, improved quality of life, and more favorable control of cardiovascular risk factors. Despite these documented benefits, participation in CR and long-term maintenance of the recommended level of PA remain insufficient. Aim of the studyThe aim of this study was to present the role of PA in secondary prevention after MI, with particular emphasis on its impact on prognosis, physical capacity, quality of life, cardiovascular risk factors, and the importance of CR. Material and methodsA narrative literature review was conducted, including observational studies, randomized clinical trials, meta-analyses, and review articles concerning PA, CR, and secondary prevention after ACS and MI. ConclusionsPA and exercise-based CR are fundamental elements of post-MI care. Their benefits include improved prognosis, physical performance, quality of life, and modification of major cardiovascular risk factors. Improving access to CR, patient education, and long-term maintenance of PA should remain one of the main goals of secondary prevention.
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
SKIN CANCER RISK IN WATER SPORTS PARTICIPANTS: ULTRAVIOLET RADIATION EXPOSURE AND PHOTOPROTECTIVE BEHAVIORS IN THE CONTEXT OF CHALLENGES AND PREVENTIVE STRATEGIES – A NARRATIVE REVIEW
Background: Water sports create a unique "high-exposure trap," significantly increasing the risk of melanoma (MSC) and non-melanoma skin cancer (NMSC) due to intense ambient UV radiation and surface reflectance. Objective: To evaluate specific risk factors and analyze the mechanical, physiological, and behavioral barriers to effective photoprotection in maritime environments. Methods: A narrative review of PubMed, Scopus, and Web of Science (February 2026) focusing on UVR exposure and protective behaviors in aquatic athletes. Results: Participants face synergistic UVR doses from direct solar radiation and surface albedo (up to 25%). Diagnosis of early damage is often hindered by the cooling effects of water/wind, which mask erythema. Standard photoprotection frequently fails due to sunscreen wash-off, chemical conjunctivitis, and thermoregulatory constraints of clothing. Professional athletes exhibit a higher incidence of field cancerization and a significant "knowledge-behavior gap" compared to recreational users. Conclusion: Generic guidelines are inadequate for the maritime setting. Specialized protocols are required, including friction-resistant sunscreen formulations and optimized UPF 50+ apparel. Mandatory dermatological screening and targeted education are essential to mitigate oncological morbidity in this high-risk population.
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessSKIN CANCER RISK IN WATER SPORTS PARTICIPANTS: ULTRAVIOLET RADIATION EXPOSURE AND PHOTOPROTECTIVE BEHAVIORS IN THE CONTEXT OF CHALLENGES AND PREVENTIVE STRATEGIES – A NARRATIVE REVIEW
Background: Water sports create a unique "high-exposure trap," significantly increasing the risk of melanoma (MSC) and non-melanoma skin cancer (NMSC) due to intense ambient UV radiation and surface reflectance. Objective: To evaluate specific risk factors and analyze the mechanical, physiological, and behavioral barriers to effective photoprotection in maritime environments. Methods: A narrative review of PubMed, Scopus, and Web of Science (February 2026) focusing on UVR exposure and protective behaviors in aquatic athletes. Results: Participants face synergistic UVR doses from direct solar radiation and surface albedo (up to 25%). Diagnosis of early damage is often hindered by the cooling effects of water/wind, which mask erythema. Standard photoprotection frequently fails due to sunscreen wash-off, chemical conjunctivitis, and thermoregulatory constraints of clothing. Professional athletes exhibit a higher incidence of field cancerization and a significant "knowledge-behavior gap" compared to recreational users. Conclusion: Generic guidelines are inadequate for the maritime setting. Specialized protocols are required, including friction-resistant sunscreen formulations and optimized UPF 50+ apparel. Mandatory dermatological screening and targeted education are essential to mitigate oncological morbidity in this high-risk population.
- Open Access
- 28 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
NEURO-ENDOCRINE-IMMUNE CROSSTALK IN CHRONIC DISEASES: AN INTEGRATIVE REVIEW OF MOLECULAR MECHANISMS, BIOMARKERS, AND PREVENTIVE STRATEGIES
Background: The growing burden of chronic non-communicable diseases has highlighted the importance of the neuro-endocrine-immune (NEI) axis as a central regulatory network integrating neural, endocrine, and immune signaling to maintain physiological homeostasis and coordinate adaptive responses to internal and environmental challenges. Increasing evidence indicates that disruption of this bidirectional communication contributes to chronic low-grade inflammation, impaired stress adaptation, and the development of multiple chronic diseases. Objective: This integrative review aims to synthesize current evidence on the molecular mechanisms, regulatory networks, biomarkers, and translational implications of neuro-endocrine-immune crosstalk, with particular emphasis on its relevance for preventive strategies and personalized medicine. Materials and Methods: An integrative review of peer-reviewed literature indexed in PubMed, Scopus, and Web of Science was conducted. The available evidence was synthesized to identify key molecular pathways, neuroimmune regulatory mechanisms, environmental sensing pathways, and clinically relevant biomarkers associated with neuro-endocrine-immune (NEI) dysregulation. Results: The available evidence indicates that disruption of NEI crosstalk promotes persistent inflammatory activation, autonomic imbalance, impaired glucocorticoid signaling, and immune dysregulation, thereby contributing to the initiation and progression of major chronic diseases. Inflammatory mediators, cortisol dynamics, autonomic indices, microbiota-derived metabolites, and environmental sensing pathways have emerged as promising biomarkers and therapeutic targets for disease prevention and risk stratification. Conclusions: The NEI axis represents a fundamental systems-level interface linking environmental exposures, stress responses, and chronic disease development. A deeper understanding of NEI crosstalk provides a scientific basis for identifying clinically relevant biomarkers and supports the development of predictive, preventive, personalized, and participatory strategies for chronic disease prevention and management.
- 28 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessNEURO-ENDOCRINE-IMMUNE CROSSTALK IN CHRONIC DISEASES: AN INTEGRATIVE REVIEW OF MOLECULAR MECHANISMS, BIOMARKERS, AND PREVENTIVE STRATEGIES
Background: The growing burden of chronic non-communicable diseases has highlighted the importance of the neuro-endocrine-immune (NEI) axis as a central regulatory network integrating neural, endocrine, and immune signaling to maintain physiological homeostasis and coordinate adaptive responses to internal and environmental challenges. Increasing evidence indicates that disruption of this bidirectional communication contributes to chronic low-grade inflammation, impaired stress adaptation, and the development of multiple chronic diseases. Objective: This integrative review aims to synthesize current evidence on the molecular mechanisms, regulatory networks, biomarkers, and translational implications of neuro-endocrine-immune crosstalk, with particular emphasis on its relevance for preventive strategies and personalized medicine. Materials and Methods: An integrative review of peer-reviewed literature indexed in PubMed, Scopus, and Web of Science was conducted. The available evidence was synthesized to identify key molecular pathways, neuroimmune regulatory mechanisms, environmental sensing pathways, and clinically relevant biomarkers associated with neuro-endocrine-immune (NEI) dysregulation. Results: The available evidence indicates that disruption of NEI crosstalk promotes persistent inflammatory activation, autonomic imbalance, impaired glucocorticoid signaling, and immune dysregulation, thereby contributing to the initiation and progression of major chronic diseases. Inflammatory mediators, cortisol dynamics, autonomic indices, microbiota-derived metabolites, and environmental sensing pathways have emerged as promising biomarkers and therapeutic targets for disease prevention and risk stratification. Conclusions: The NEI axis represents a fundamental systems-level interface linking environmental exposures, stress responses, and chronic disease development. A deeper understanding of NEI crosstalk provides a scientific basis for identifying clinically relevant biomarkers and supports the development of predictive, preventive, personalized, and participatory strategies for chronic disease prevention and management.
- Open Access
- 27 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 65, 73070
Nutritional Deficiencies in Crohn’s Disease: Pathogenesis, Clinical Significance, and Therapeutic Management
Crohn’s disease (CD) is a chronic, relapsing-remitting inflammatory disorder of the gastrointestinal tract in which impaired nutritional status and nutritional deficiencies are common. This issue is of major clinical relevance, as deficiencies in both macro- and micronutrients not only reflect disease activity but may also influence disease course, treatment efficacy, and patients’ quality of life. The pathogenesis of nutritional deficiencies in Crohn’s disease is multifactorial and includes malabsorption, reduced dietary intake, increased metabolic demand, nutrient loss, and the effects of pharmacotherapy. The most frequently observed deficiencies involve protein and energy, iron, vitamin B12, vitamin D, folate, and selected minerals such as zinc and magnesium. Their clinical consequences include anemia, impaired bone mineralization, immune dysfunction, delayed tissue repair, and overall deterioration in health status. The problem is particularly important in the pediatric population, in whom deficiencies may result in impaired growth and development. The aim of this review was to present the mechanisms leading to nutritional deficiencies in Crohn’s disease, discuss their clinical significance, and summarize current diagnostic and therapeutic strategies. The available evidence indicates that systematic nutritional assessment and appropriately selected nutritional interventions should constitute an integral part of comprehensive patient care.
- 27 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 65, 73070
Open AccessNutritional Deficiencies in Crohn’s Disease: Pathogenesis, Clinical Significance, and Therapeutic Management
Crohn’s disease (CD) is a chronic, relapsing-remitting inflammatory disorder of the gastrointestinal tract in which impaired nutritional status and nutritional deficiencies are common. This issue is of major clinical relevance, as deficiencies in both macro- and micronutrients not only reflect disease activity but may also influence disease course, treatment efficacy, and patients’ quality of life. The pathogenesis of nutritional deficiencies in Crohn’s disease is multifactorial and includes malabsorption, reduced dietary intake, increased metabolic demand, nutrient loss, and the effects of pharmacotherapy. The most frequently observed deficiencies involve protein and energy, iron, vitamin B12, vitamin D, folate, and selected minerals such as zinc and magnesium. Their clinical consequences include anemia, impaired bone mineralization, immune dysfunction, delayed tissue repair, and overall deterioration in health status. The problem is particularly important in the pediatric population, in whom deficiencies may result in impaired growth and development. The aim of this review was to present the mechanisms leading to nutritional deficiencies in Crohn’s disease, discuss their clinical significance, and summarize current diagnostic and therapeutic strategies. The available evidence indicates that systematic nutritional assessment and appropriately selected nutritional interventions should constitute an integral part of comprehensive patient care.
- Open Access
- 14 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 64, 73626
Exercise-induced BDNF signaling mediates neuroplasticity in depression
Background.Major depressive disorder (MDD) is increasingly recognized as a disorder of impaired neuroplasticity. Brain-derived neurotrophic factor (BDNF) plays a central role in neuronal survival, synaptic plasticity, and antidepressant mechanisms [1–4]. Physical exercise has emerged as an effective non-pharmacological intervention capable of enhancing BDNF signaling and promoting neuroplastic adaptations [20–27]. Aim.To summarize current evidence on the role of exercise-induced BDNF signaling in mediating neuroplastic adaptations and antidepressant effects in depression. Material and methods.A narrative review of peer-reviewed studies, including mechanistic research, randomized controlled trials, cohort studies, and meta-analyses, was conducted. Evidence from neuroscience, exercise physiology, and clinical psychiatry was integrated. Results.Exercise increases BDNF expression through multiple biological pathways, including lactate signaling, muscle–brain crosstalk, and kynurenine metabolism [8–10]. These adaptations promote neurogenesis, synaptic plasticity, and improvements in brain connectivity [11,12,16,17]. Meta-analyses demonstrate that exercise increases circulating BDNF levels and reduces depressive symptoms [14,15,22]. Epidemiological and clinical studies indicate that higher physical activity is associated with a lower risk of depression and improved mental health outcomes [20–30]. Conclusions.BDNF appears to be a key mediator of the antidepressant effects of exercise. Current evidence supports the inclusion of structured physical activity as an evidence-based component of depression treatment, although further research is needed to optimize exercise protocols and clarify individual differences in BDNF responsiveness.
- 14 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 64, 73626
Open AccessExercise-induced BDNF signaling mediates neuroplasticity in depression
Background.Major depressive disorder (MDD) is increasingly recognized as a disorder of impaired neuroplasticity. Brain-derived neurotrophic factor (BDNF) plays a central role in neuronal survival, synaptic plasticity, and antidepressant mechanisms [1–4]. Physical exercise has emerged as an effective non-pharmacological intervention capable of enhancing BDNF signaling and promoting neuroplastic adaptations [20–27]. Aim.To summarize current evidence on the role of exercise-induced BDNF signaling in mediating neuroplastic adaptations and antidepressant effects in depression. Material and methods.A narrative review of peer-reviewed studies, including mechanistic research, randomized controlled trials, cohort studies, and meta-analyses, was conducted. Evidence from neuroscience, exercise physiology, and clinical psychiatry was integrated. Results.Exercise increases BDNF expression through multiple biological pathways, including lactate signaling, muscle–brain crosstalk, and kynurenine metabolism [8–10]. These adaptations promote neurogenesis, synaptic plasticity, and improvements in brain connectivity [11,12,16,17]. Meta-analyses demonstrate that exercise increases circulating BDNF levels and reduces depressive symptoms [14,15,22]. Epidemiological and clinical studies indicate that higher physical activity is associated with a lower risk of depression and improved mental health outcomes [20–30]. Conclusions.BDNF appears to be a key mediator of the antidepressant effects of exercise. Current evidence supports the inclusion of structured physical activity as an evidence-based component of depression treatment, although further research is needed to optimize exercise protocols and clarify individual differences in BDNF responsiveness.
- Open Access
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
SARCOPENIC OBESITY IN THE ERA OF INCRETIN-BASED THERAPIES: DIAGNOSTIC CHALLENGES, THE RISK OF MUSCLE MASS LOSS, AND PREVENTION STRATEGIES
Introduction and purpose. Sarcopenic obesity (SO) is defined by the coexistence of excess adiposity and reduced muscle mass and function and is associated with disability, frailty, cardiometabolic disease, and increased mortality. This review aims to summarize current evidence on the definition and diagnosis of SO, assess the effects of incretin-based therapies on body composition, with a focus on practical strategies to reduce the risk of clinically relevant muscle loss during obesity treatment. Material and methods. This manuscript was prepared as a structured narrative review based on publications identified in PubMed/MEDLINE, Google Scholar, and the Cochrane Library. Results. Current evidence suggests that semaglutide and tirzepatide produce significant and sustained reductions in body weight and fat mass, including visceral adipose tissue, while also being associated with a decrease in absolute lean body mass. These changes should not be interpreted automatically as clinically relevant skeletal muscle loss. However, older adults, frail individuals, and patients with low muscle reserve are more susceptible, especially without adequate protein intake, resistance exercise, and regular monitoring. Conclusions. Incretin-based therapies represent a major advance in obesity treatment; however, in patients at risk of SO, they should be used within a multimodal strategy aimed at preserving muscle mass and function.
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
Open AccessSARCOPENIC OBESITY IN THE ERA OF INCRETIN-BASED THERAPIES: DIAGNOSTIC CHALLENGES, THE RISK OF MUSCLE MASS LOSS, AND PREVENTION STRATEGIES
Introduction and purpose. Sarcopenic obesity (SO) is defined by the coexistence of excess adiposity and reduced muscle mass and function and is associated with disability, frailty, cardiometabolic disease, and increased mortality. This review aims to summarize current evidence on the definition and diagnosis of SO, assess the effects of incretin-based therapies on body composition, with a focus on practical strategies to reduce the risk of clinically relevant muscle loss during obesity treatment. Material and methods. This manuscript was prepared as a structured narrative review based on publications identified in PubMed/MEDLINE, Google Scholar, and the Cochrane Library. Results. Current evidence suggests that semaglutide and tirzepatide produce significant and sustained reductions in body weight and fat mass, including visceral adipose tissue, while also being associated with a decrease in absolute lean body mass. These changes should not be interpreted automatically as clinically relevant skeletal muscle loss. However, older adults, frail individuals, and patients with low muscle reserve are more susceptible, especially without adequate protein intake, resistance exercise, and regular monitoring. Conclusions. Incretin-based therapies represent a major advance in obesity treatment; however, in patients at risk of SO, they should be used within a multimodal strategy aimed at preserving muscle mass and function.
- Open Access
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
RECENT ADVANCES IN AUTOPHAGY AND VESICLE TRAFFICKING IN PANCREATIC DISEASES: MOLECULAR MECHANISMS AND SELECTIVE AUTOPHAGY PATHWAYS
Autophagy is a key lysosome-dependent degradation pathway essential for maintaining cellular homeostasis, particularly in the highly secretory pancreas. This review summarizes recent advances in autophagy, selective autophagy, and vesicle trafficking in pancreatic physiology and disease. We focus on the dual role of autophagy, which can support cellular protection and organelle quality control, but also contribute to pathology when dysregulated. We highlight emerging molecular mechanisms linking autophagy with vesicle trafficking systems, including membrane remodeling, organelle contact sites, and key regulators such as VMP1 and Beclin-1. In addition, we discuss the role of autophagy in pancreatic inflammation and cancer, emphasizing its context-dependent function. Finally, we outline recent translational approaches targeting autophagy-related pathways, including pharmacological and genetic strategies, with potential diagnostic and therapeutic relevance in pancreatic diseases.
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
Open AccessRECENT ADVANCES IN AUTOPHAGY AND VESICLE TRAFFICKING IN PANCREATIC DISEASES: MOLECULAR MECHANISMS AND SELECTIVE AUTOPHAGY PATHWAYS
Autophagy is a key lysosome-dependent degradation pathway essential for maintaining cellular homeostasis, particularly in the highly secretory pancreas. This review summarizes recent advances in autophagy, selective autophagy, and vesicle trafficking in pancreatic physiology and disease. We focus on the dual role of autophagy, which can support cellular protection and organelle quality control, but also contribute to pathology when dysregulated. We highlight emerging molecular mechanisms linking autophagy with vesicle trafficking systems, including membrane remodeling, organelle contact sites, and key regulators such as VMP1 and Beclin-1. In addition, we discuss the role of autophagy in pancreatic inflammation and cancer, emphasizing its context-dependent function. Finally, we outline recent translational approaches targeting autophagy-related pathways, including pharmacological and genetic strategies, with potential diagnostic and therapeutic relevance in pancreatic diseases.
- Open Access
- 16 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 55
Is lipohypertrophy marely a cosmetic defect? The impact of lipohypertrophy on treatment and lives of patients with diabetes - a literature review
Background: : Lipohipertrophy (LH) is a common complication of diabetes, regardless of its type, in which the tissue exposed to insuline lead to hypertrophy of adipocytes and fibrosis. Despite it looks like only a visual problem, it has many negative consequences, that pose a threat to patients' health, lives, and quality of life. Aim: In this article we would like to present the multiple dimensions affected by this complication, as well as the potential benefits associated with the treatment of LH. Methods: A narrative review was conducted using the medical databases PubMed, Google Scholar, and ScienceDirect, with a focus on the impact of insulin-induced LH on the health and daily functioning of patients with diabetes. Results: The following aspects were analyzed: the impact of LH on glycemic control, risks associated with glycemic variability, long-term complications, quality of life, effects on the management of comorbidities, mental health, and treatment-related costs. Each of these domains was found to be significantly impaired or complicated by the presence of LH. Furthermore, improvements in patient health outcomes were observed in cases where regression of LH lesions was achieved. Conclusion: The entirety of the reviewed literature indicates that LH constitutes a substantial clinical challenge. Early detection, prevention, and effective management are essential for improving disease control and enhancing the quality of life for patients with diabetes.
- 16 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 55
Open AccessIs lipohypertrophy marely a cosmetic defect? The impact of lipohypertrophy on treatment and lives of patients with diabetes - a literature review
Background: : Lipohipertrophy (LH) is a common complication of diabetes, regardless of its type, in which the tissue exposed to insuline lead to hypertrophy of adipocytes and fibrosis. Despite it looks like only a visual problem, it has many negative consequences, that pose a threat to patients' health, lives, and quality of life. Aim: In this article we would like to present the multiple dimensions affected by this complication, as well as the potential benefits associated with the treatment of LH. Methods: A narrative review was conducted using the medical databases PubMed, Google Scholar, and ScienceDirect, with a focus on the impact of insulin-induced LH on the health and daily functioning of patients with diabetes. Results: The following aspects were analyzed: the impact of LH on glycemic control, risks associated with glycemic variability, long-term complications, quality of life, effects on the management of comorbidities, mental health, and treatment-related costs. Each of these domains was found to be significantly impaired or complicated by the presence of LH. Furthermore, improvements in patient health outcomes were observed in cases where regression of LH lesions was achieved. Conclusion: The entirety of the reviewed literature indicates that LH constitutes a substantial clinical challenge. Early detection, prevention, and effective management are essential for improving disease control and enhancing the quality of life for patients with diabetes.
- 13 January 2026
- Published by Springer Nature in Rheumatology International
- Vol. 46 (1) , 32
Tofacitinib treatment in a girl with localized scleroderma of the head and face: a case-based review
- 13 January 2026
- Published by Springer Nature in Rheumatology International
- Vol. 46 (1) , 32
Tofacitinib treatment in a girl with localized scleroderma of the head and face: a case-based review